New study tracks TB drugs in breastmilk to protect infants
NCT ID NCT05840809
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how tuberculosis (TB) medications travel through a mother's body, into her breastmilk, and to her nursing baby. Researchers will take blood and milk samples from 20 mothers and small blood samples from their infants at several time points after a dose. The goal is to understand drug levels so doctors can better treat TB in breastfeeding women while keeping babies safe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREASTFEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Infectious Diseases Institute
Kampala, Kampala, 22418, Uganda
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tongue-Tie and breastfeeding: a closer look at the first six months
- Could calming Moms-to-Be boost baby brain health?
- Can a shorter TB regimen transform child care?
- Boosting breastfeeding confidence in teen moms: a new approach put to the test
- Can immune profiling unlock the hidden stages of tuberculosis?
- Could a daily vitamin pill fortify breast milk for the tiniest babies?